Tag results:
mesenchymal stem cells
Hematopoiesis News
Effects of Bone Marrow-Derived Mesenchymal Stem Cells Exposed to Endocrine-Disrupting Chemicals on the Differentiation of Umbilical Cord Blood Hematopoietic Stem Cells
[Environmental Science and Pollution Research] Scientists investigated the effect of Bisphenol A and diethylhexyl phthalate on the clonogenic capacity of umbilical cord blood HSCs.
Cell Therapy News
In Vivo Tracking of Unlabelled Mesenchymal Stromal Cells by Mannose-Weighted Chemical Exchange Saturation Transfer MRI
[Nature Biomedical Engineering] The authors showed that high-mannose N-linked glycans could serve as a biomarker for the label-free tracking of transplanted human mesenchymal stem cells by mannose-weighted chemical exchange saturation transfer magnetic resonance imaging.
Cell Therapy News
Regenerative Medicine for Male Infertility: A Focus on Stem Cell Niche Injury Models
[Biomedical Journal] In a bid to consider mesenchymal stem cells and their secretome as a therapeutic regenerative approach for idiopathic male infertility, the authors focus on the rationale of spermatogonial stem cell niche injury modeling.
Hepatic Cell News
NorthSea Therapeutics Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease
[NorthSea Therapeutics B.V.] NorthSea Therapeutics B.V. announced it has initiated a Phase I study with SEFA-6179 in adult subjects, targeting the initial orphan indication of the treatment of intestinal failure associated liver disease.
Mammary Cell News
Engineer a Pre-Metastatic Niched Microenvironment to Attract Breast Cancer Cells by Utilizing a 3D Printed Polycaprolactone/Nano-Hydroxyapatite Osteogenic Scaffold – an In Vitro Model System...
[Journal of Biomedical Materials Research Part B-Applied Biomaterials] A transwell migration assay was used to investigate recruitment of MDA-MB-231, MCF-7, and MDA-MB-453 breast cancer cells to the osseous polycaprolactone-nano-hydroxyapatite scaffolds.
Mesenchymal Cell News
NEAT1 in Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Promotes Melanoma by Inducing M2 Macrophage Polarization
[Cancer Gene Therapy] Researchers demonstrated that bone marrow MSC-derived extracellular vesicles carrying NEAT1 could promote the progression of melanoma by inducing M2 polarization of macrophages, and thus may be considered as a potential target for melanoma therapeutics.